Price 6 Months Forecast & Ratings

Sign up to access Target Price

Sign up

AI Score



Sign up to see AI score

Brand Score 65
Employment Score 72
User Growth Score 42
Fundamental Score 45

What is the target price for Tarsus Pharmaceuticals?

On October 31, an AI target price of Premium - Sign up was allocated to Tarsus Pharmaceuticals (TARS). This projected target price was predicated on several factors, including a longterm increase in Twitter followers, a longterm increase in Instagram followers, a month over month spike in job posts, an encouraging high employee satisfaction, and an encouraging high business outlook across the company's employees.

Is TARS a Buy, Sell or Hold?

Based on Alternative Data, Tarsus Pharmaceuticals is a buy.

Should I buy TARS stock?

Based on the data provided, it's advisable to consider buying Tarsus Pharmaceuticals (TARS) stock. The observed positive trends all contribute to a buy signal. However, this information should not be considered financial advice. Like any investment choice, it's important to conduct comprehensive research, not only utilizing alternative data, but also considering the company's financials, industry trends, and recent news developments.

What Is the TARS Stock Forecast for 2025?

With an AI score of 63, the TARS stock forecast indicates a positive outlook.

What is the TARS price prediction for 2025?

To predict the price for TARS in 2025, we can extrapolate the AI price target. This approach projects TARS's price to reach $47.34.

What is the TARS price prediction for 2030?

To predict the price for TARS in 2030, we can again extrapolate the AI price target. This approach projects TARS's price to reach $54.64.

How do we predict the price for TARS?

When predicting the price for TARS, our approach incorporates multiple scores assessing different aspects of the company. The Brand score measures growth and engagement across social media channels, indicating audience reach. The Employee score evaluates workforce health, considering job postings, business outlook, and employee ratings. The Customer score examines engagement on websites, app downloads, and sentiment in stock forums. Lastly, the Fundamental score analyzes financial statements and analyst ratings. By evaluating this data, we gain a holistic view of the company's performance, enabling more informed price predictions.

Will TARS go up tomorrow?

Based on technical analysis of how the price has moved over the last 6 months, the likelihood of the price going up tomorrow is 38%.
Note that this is a simplistic analysis and should be used with caution, as prices are influenced by a myriad of factors.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.